@superposition.bsky.socialIonQ lands $2.0 billion to expand quantum computing reach #ionq #astrazeneca
@pharmalot.bsky.socialPharmalot.. Pharmalittle.. Good Morning: We’re reading about former FDA head calling DOGE a ‘disaster,’ an AstraZeneca AI deal, and more news.. statnews.com/pharmalot/20... #pharma #FDA #AI #AstraZeneca #DOGE #cancer #vaccine #weight #obesity #SouthAfrica #Roche #schizophrenia
@pxology.bsky.socialAstraZeneca, insitro ile AI destekli ilaç keşfi anlaşması yaptı: 40 milyon dolar peşin, başarıya bağlı ek ödemeler mümkün.
#AstraZeneca #insitro #YapayZeka #AIScience #YZ #AI
🌐Kaynak:
www.reuters.com/legal/litiga...
@quartzmedia.bsky.socialAstraZeneca bets $40M on AI to crack liver and heart diseases it's struggled to crack alone #AstraZeneca #AI
@thedailyfathom.bsky.socialBIOTECH · AstraZeneca's bone disease drug fails late-stage trial
Efzimfotase alfa missed its goal in a rare bone disease trial. AstraZeneca blames the study's design, not the drug.
@pharmaphorum.bsky.social#AstraZeneca has already filed for approval of its therapy for ultra-rare disease #hypophosphatasia (HPP), after missing the mark in a phase 3 trial, but reckons the totality of the data could get the drug over the line with a broad label.
@quartzmedia.bsky.socialICYMI: AstraZeneca just made Kendall Square its global R&D flagship #AstraZeneca #ResearchAndDevelopment
@pharmalot.bsky.socialPharmalot.. Pharmalittle.. Good Morning: We’re reading about U.S.-funded psychedelic trials, an AstraZeneca R&D center, and more news.. statnews.com/pharmalot/20... #Trump #psychedelics #AstraZeneca #CSL #Shionogi #pharmacies #Medicare #GE
@pharmaphorum.bsky.social#AstraZeneca's pivot toward the #US market has continued with the opening of a new R&D centre in the #biotechhotspot of Cambridge, Massachusetts, the centrepiece of a $1 billion #investment programme in the state.
@quartzmedia.bsky.socialAstraZeneca just made Kendall Square its global R&D flagship #AstraZeneca #HealthcareInnovation
@newsen.bsky.socialThe Growing SERD Market: Key Drivers and Future Projections Through 2036 #None #AstraZeneca #ETCAMAH #SERD
@jedisrien.bsky.socialUn beau cadeau de la sécu à #astrazeneca 😵😵😵
@pharmafakten.bsky.socialTessa Wolf von #AstraZeneca Deutschland erzählt im Interview, was die forschende #Pharmaindustrie braucht, um Deutschlands #Gesundheit, #Wirtschaft und Unabhängigkeit zu stärken: pharma-fakten.de/news/herbst-...
@consalud.bsky.social#Pacientes | 🦠 La #gripe deja huella más allá de los síntomas
➡️ La campaña #LaHuellaDeLaGripe de #AstraZeneca anima a anticiparse
@pharmalot.bsky.socialPharmalot.. Pharmalittle.. Good Morning: We’re reading about Trump's plan to lower Medicare drug prices, a Lilly obesity drug, and more news.. statnews.com/pharmalot/20... #pharma #Trump #Medicare #obesity #weight #layoffs #FDA #animals #Lilly #Novo #AstraZeneca #Sanofi #Regeneron
@4040rec.bsky.social@pharmalot.bsky.socialPharmalot.. Pharmalittle.. Good Morning: We’re reading about Novo licensing a Chinese obesity pill, Merck pulling an antibiotic, and more news.. statnews.com/pharmalot/20... #pharma #obesity #antibiotic #jobs #China #weight #Novo #Roche #Merck #AstraZeneca #Baltimore #Bausch
@pharmaphorum.bsky.social#AstraZeneca has taken a roughly 10% stake in Summit Therapeutics for $2bn, signing a deal to test CLDN18.2-targeting #ADC sone-ve with PD-1xVEGF bispecific ivonescimab.
@pharmalot.bsky.socialPharmalot.. Pharmalittle.. Good Morning: We’re reading about a reticent FDA commish nominee, a Novo deal, and more news.. statnews.com/pharmalot/20... #pharma #FDA #Overton #Lilly #Novo #AstraZeneca #patents #Indonesia
@pharmaphorum.bsky.social#AstraZeneca could be just months away from #FDA approval of a new #bladdercancer indication for its #PDL1inhibitor #Imfinzi, which is viewed as key to meeting its sales ambitions for the drug.
